On page 1886, in Figure 1C, in the sea-level graph, 5 data points are missing. In the 5100-m graph, 2 data points are missing: 1 for CMS− participants and 1 for CMS+ participants. The corrected Figure 1C is shown below.
No association between excessive erythrocytosis and CMS score at 5100 m. (A-C) Individual intravascular volumes of participants categorized into no CMS (CMS−) and CMS (CMS+) with the CMS score including the [Hb] criterion. Erythrocytosis was determined by RBCV measurement. The effect of altitude was assessed with a Kruskal-Wallis test including all participants. Pairwise comparisons using a Mann-Whitney U test with Bonferroni correction were performed and visualized with brackets above the graphs. The effect of CMS at 3800 m or 5100 m was assessed with a Mann-Whitney U test with $P < .01 vs CMS−. Lines indicate median and interquartile range. BV, blood volume.
No association between excessive erythrocytosis and CMS score at 5100 m. (A-C) Individual intravascular volumes of participants categorized into no CMS (CMS−) and CMS (CMS+) with the CMS score including the [Hb] criterion. Erythrocytosis was determined by RBCV measurement. The effect of altitude was assessed with a Kruskal-Wallis test including all participants. Pairwise comparisons using a Mann-Whitney U test with Bonferroni correction were performed and visualized with brackets above the graphs. The effect of CMS at 3800 m or 5100 m was assessed with a Mann-Whitney U test with $P < .01 vs CMS−. Lines indicate median and interquartile range. BV, blood volume.
![No association between excessive erythrocytosis and CMS score at 5100 m. (A-C) Individual intravascular volumes of participants categorized into no CMS (CMS−) and CMS (CMS+) with the CMS score including the [Hb] criterion. Erythrocytosis was determined by RBCV measurement. The effect of altitude was assessed with a Kruskal-Wallis test including all participants. Pairwise comparisons using a Mann-Whitney U test with Bonferroni correction were performed and visualized with brackets above the graphs. The effect of CMS at 3800 m or 5100 m was assessed with a Mann-Whitney U test with $P < .01 vs CMS−. Lines indicate median and interquartile range. BV, blood volume.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/143/22/10.1182_blood.2024024112/2/m_blood_bld-2024-024112-gr1c.jpeg?Expires=1766011476&Signature=ewJAtteZp-S7Nd4IlqCO~8oOqmIQYO-LR~4oHfPndusrKxOljyHEkNyrfmdbdBAYsQm~KSpHG0b3zL~1Mi42y4OQ8IZ-kDoAVQsYzU8KgDSP~H8wFnmbgDvopgEYQBQqIPxZ08QY0OtmOIOq5~dOxdU0lP-5HAYUn9HZE7HknEm8uilEeXI7Cpc1v-uFlLyy~Yp3mPxBVlsNsim1-QRE6~el2A-67bacSEPKBu-nEtRcsjWGWdWyjpTfVTYnjymUxPf4baRyOdk~9pVlMcHODccDgBhAPUDNtaGvCCWqetrFzhujSodx4U~BxOVdifzhxj4U2h8SKRfGVLbTniEUlg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
![No association between excessive erythrocytosis and CMS score at 5100 m. (A-C) Individual intravascular volumes of participants categorized into no CMS (CMS−) and CMS (CMS+) with the CMS score including the [Hb] criterion. Erythrocytosis was determined by RBCV measurement. The effect of altitude was assessed with a Kruskal-Wallis test including all participants. Pairwise comparisons using a Mann-Whitney U test with Bonferroni correction were performed and visualized with brackets above the graphs. The effect of CMS at 3800 m or 5100 m was assessed with a Mann-Whitney U test with $P < .01 vs CMS−. Lines indicate median and interquartile range. BV, blood volume.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/143/22/10.1182_blood.2024024112/2/m_blood_bld-2024-024112-gr1c.jpeg?Expires=1766011477&Signature=z9GI3a0VbsditSRbzDTHnDI2XwNnXoWQMM--j179h2eISbXELbuJDjShyO4x8Bf7VAqupG6pr6-bR1Yv36TVtPBEDLTzDOWphnW8z38ML3olPr1mV~8GIHCdCqkes0ZFHbs5DVDbtJZXU9YmaKIx4CRQ-KzSPj5ALQeQBnflfaHdmLElYWNMXpbNHZV1No1ZTSU6vgorN-UeLuqiajf~0kNmf7vTi4dr5Xwj1ATkTWA89mdAhFi2UYMwa77uZPghaYtavuBrk-tr1P1Kj2r9lmU25Kd66zkI6gaW-ro5UZmz7bPFVFJJnNUXCccrVL4RBbKkoLDLXUVpZeXc69QVHg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)